UPDATE: Federal Court Denies Sequenom Preliminary Injunction Against Ariosa | GenomeWeb

The story has been updated to include comments by Sequenom.

NEW YORK (GenomeWeb News) – Ariosa Diagnostics today said that Sequenom's motion for a preliminary injunction against it has been denied by a federal court.

The US District Court for the Northern District of California has denied Sequenom's motion to prevent Ariosa from offering or selling its Harmony Prenatal Test, pending the ultimate resolution of the litigation between the two firms, Ariosa said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.